Literature DB >> 12495131

Simultaneous inferences on the contrast of two hazard functions with censored observations.

Peter B Gilbert1, L J Wei, Michael R Kosorok, John D Clemens.   

Abstract

In survival analysis, often times the pattern of instantaneous risk over time is more interesting than that of the cumulative risk. For this case, a nonparametric hazard function estimate is more appropriate for summarizing the risk experience of a group of patients than the corresponding Kaplan-Meier estimate. In comparing a new treatment with a standard therapy, it is important to know if the treatment loses it potency during the follow-up period, and if it does, one would like to know when it becomes ineffective. Unfortunately, with a plot of the differences of two Kaplan-Meier curves, it is rather difficult to capture such temporal trends. In this article, we propose simple procedures for constructing confidence bands for the contrast of two hazard functions with censored data. The simultaneous interval estimates are quite useful for identifying possible values of the contrast over time with a certain degree of confidence. The new proposals are illustrated with an example and a small simulation study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12495131     DOI: 10.1111/j.0006-341x.2002.00773.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  19 in total

1.  Non-parametric estimation of a time-dependent predictive accuracy curve.

Authors:  P Saha-Chaudhuri; P J Heagerty
Journal:  Biostatistics       Date:  2012-06-25       Impact factor: 5.899

2.  Estimation of the 2-sample hazard ratio function using a semiparametric model.

Authors:  Song Yang; Ross L Prentice
Journal:  Biostatistics       Date:  2010-09-21       Impact factor: 5.899

3.  Predicting the restricted mean event time with the subject's baseline covariates in survival analysis.

Authors:  Lu Tian; Lihui Zhao; L J Wei
Journal:  Biostatistics       Date:  2013-11-29       Impact factor: 5.899

4.  How Do the Accrual Pattern and Follow-Up Duration Affect the Hazard Ratio Estimate When the Proportional Hazards Assumption Is Violated?

Authors:  Miki Horiguchi; Michael J Hassett; Hajime Uno
Journal:  Oncologist       Date:  2018-09-10

5.  Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis.

Authors:  Hajime Uno; Brian Claggett; Lu Tian; Eisuke Inoue; Paul Gallo; Toshio Miyata; Deborah Schrag; Masahiro Takeuchi; Yoshiaki Uyama; Lihui Zhao; Hicham Skali; Scott Solomon; Susanna Jacobus; Michael Hughes; Milton Packer; Lee-Jen Wei
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

6.  Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Authors:  Glenda E Gray; Mary Allen; Zoe Moodie; Gavin Churchyard; Linda-Gail Bekker; Maphoshane Nchabeleng; Koleka Mlisana; Barbara Metch; Guy de Bruyn; Mary H Latka; Surita Roux; Matsontso Mathebula; Nivashnee Naicker; Constance Ducar; Donald K Carter; Adrien Puren; Niles Eaton; M Julie McElrath; Michael Robertson; Lawrence Corey; James G Kublin
Journal:  Lancet Infect Dis       Date:  2011-05-11       Impact factor: 25.071

7.  Assessing potentially time-dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial.

Authors:  Song Yang; Ross L Prentice
Journal:  Stat Med       Date:  2015-02-17       Impact factor: 2.373

8.  Estimating subject-specific dependent competing risk profile with censored event time observations.

Authors:  Yi Li; Lu Tian; Lee-Jen Wei
Journal:  Biometrics       Date:  2010-07-09       Impact factor: 2.571

9.  A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomes.

Authors:  Song Yang; Walter T Ambrosius; Lawrence J Fine; Adam P Bress; William C Cushman; Dominic S Raj; Shakaib Rehman; Leonardo Tamariz
Journal:  Clin Trials       Date:  2018-04-19       Impact factor: 2.486

10.  Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

Authors:  Daniel Sargent; Alberto Sobrero; Axel Grothey; Michael J O'Connell; Marc Buyse; Thierry Andre; Yan Zheng; Erin Green; Roberto Labianca; Chris O'Callaghan; Jean Francois Seitz; Guido Francini; Daniel Haller; Greg Yothers; Richard Goldberg; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2009-01-05       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.